Data as of Nov 21
| +2.47 / +2.46%|
The 16 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 109.50, with a high estimate of 190.00 and a low estimate of 88.00. The median estimate represents a +6.41% increase from the last price of 102.90.
The current consensus among 19 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.